Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues | Pharmaceutical Commerce
Novo Nordisk's Bloomington Plant Receives FDA OAI Designation The Novo Nordisk facility in Bloomington, IN, has received an official action indicated (OAI) label from the FDA due to contam…